193 related articles for article (PubMed ID: 29253496)
1. Development of an in vivo infection model to study Mouse papillomavirus-1 (MmuPV1).
Uberoi A; Yoshida S; Lambert PF
J Virol Methods; 2018 Mar; 253():11-17. PubMed ID: 29253496
[TBL] [Abstract][Full Text] [Related]
2. Rodent Papillomaviruses.
Uberoi A; Lambert PF
Viruses; 2017 Nov; 9(12):. PubMed ID: 29186900
[TBL] [Abstract][Full Text] [Related]
3. Spontaneous and Vaccine-Induced Clearance of Mus Musculus Papillomavirus 1 Infection.
Jiang RT; Wang JW; Peng S; Huang TC; Wang C; Cannella F; Chang YN; Viscidi RP; Best SRA; Hung CF; Roden RBS
J Virol; 2017 Aug; 91(15):. PubMed ID: 28515303
[TBL] [Abstract][Full Text] [Related]
4. A Novel Model for Papillomavirus-Mediated Anal Disease and Cancer Using the Mouse Papillomavirus.
Blaine-Sauer S; Shin MK; Matkowskyj KA; Ward-Shaw E; Lambert PF
mBio; 2021 Aug; 12(4):e0161121. PubMed ID: 34281391
[TBL] [Abstract][Full Text] [Related]
5. Key aspects of papillomavirus infection influence the host cervicovaginal microbiome in a preclinical murine papillomavirus (MmuPV1) infection model.
Spurgeon ME; Townsend EC; Blaine-Sauer S; McGregor SM; Horswill M; den Boon JA; Ahlquist P; Kalan L; Lambert PF
mBio; 2024 Jun; 15(6):e0093324. PubMed ID: 38742830
[TBL] [Abstract][Full Text] [Related]
6. A Novel
Spurgeon ME; Uberoi A; McGregor SM; Wei T; Ward-Shaw E; Lambert PF
mBio; 2019 Mar; 10(2):. PubMed ID: 30837335
[TBL] [Abstract][Full Text] [Related]
7. An Infection-Based Murine Model for Papillomavirus-Associated Head and Neck Cancer.
Wei T; Buehler D; Ward-Shaw E; Lambert PF
mBio; 2020 May; 11(3):. PubMed ID: 32398315
[TBL] [Abstract][Full Text] [Related]
8. Role of Ultraviolet Radiation in Papillomavirus-Induced Disease.
Uberoi A; Yoshida S; Frazer IH; Pitot HC; Lambert PF
PLoS Pathog; 2016 May; 12(5):e1005664. PubMed ID: 27244228
[TBL] [Abstract][Full Text] [Related]
9. The Mouse Papillomavirus Infection Model.
Hu J; Cladel NM; Budgeon LR; Balogh KK; Christensen ND
Viruses; 2017 Aug; 9(9):. PubMed ID: 28867783
[TBL] [Abstract][Full Text] [Related]
10. T cell-mediated antitumor immune response eliminates skin tumors induced by mouse papillomavirus, MmuPV1.
Joh J; Chilton PM; Wilcher SA; Zahin M; Park J; Proctor ML; Ghim SJ; Jenson AB
Exp Mol Pathol; 2017 Oct; 103(2):181-190. PubMed ID: 28939161
[TBL] [Abstract][Full Text] [Related]
11. The full transcription map of mouse papillomavirus type 1 (MmuPV1) in mouse wart tissues.
Xue XY; Majerciak V; Uberoi A; Kim BH; Gotte D; Chen X; Cam M; Lambert PF; Zheng ZM
PLoS Pathog; 2017 Nov; 13(11):e1006715. PubMed ID: 29176795
[TBL] [Abstract][Full Text] [Related]
12. The Larynx is Protected from Secondary and Vertical Papillomavirus Infection in Immunocompetent Mice.
King RE; Rademacher J; Ward-Shaw ET; Hu R; Bilger A; Blaine-Sauer S; Spurgeon ME; Thibeault SL; Lambert PF
Laryngoscope; 2024 May; 134(5):2322-2330. PubMed ID: 38084790
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in preclinical model systems for papillomaviruses.
Christensen ND; Budgeon LR; Cladel NM; Hu J
Virus Res; 2017 Mar; 231():108-118. PubMed ID: 27956145
[TBL] [Abstract][Full Text] [Related]
14. A Novel In Vivo Model of Laryngeal Papillomavirus-Associated Disease Using
King RE; Bilger A; Rademacher J; Ward-Shaw ET; Hu R; Lambert PF; Thibeault SL
Viruses; 2022 May; 14(5):. PubMed ID: 35632742
[TBL] [Abstract][Full Text] [Related]
15. A novel lineage-tracing mouse model for studying early MmuPV1 infections.
Yilmaz V; Louca P; Potamiti L; Panayiotidis M; Strati K
Elife; 2022 May; 11():. PubMed ID: 35533001
[TBL] [Abstract][Full Text] [Related]
16. MmuPV1 infection and tumor development of T cell-deficient mice is prevented by passively transferred hyperimmune sera from normal congenic mice immunized with MmuPV1 virus-like particles (VLPs).
Joh J; Ghim SJ; Chilton PM; Sundberg JP; Park J; Wilcher SA; Proctor ML; Bennett Jenson A
Exp Mol Pathol; 2016 Feb; 100(1):212-9. PubMed ID: 26778691
[TBL] [Abstract][Full Text] [Related]
17. A Mouse Model of Oropharyngeal Papillomavirus-Induced Neoplasia Using Novel Tools for Infection and Nasal Anesthesia.
Bilger A; King RE; Schroeder JP; Piette JT; Hinshaw LA; Kurth AD; AlRamahi RW; Barthel MV; Ward-Shaw ET; Buehler D; Masters KS; Thibeault SL; Lambert PF
Viruses; 2020 Apr; 12(4):. PubMed ID: 32316091
[TBL] [Abstract][Full Text] [Related]
18. MmuPV1 E7's interaction with PTPN14 delays Epithelial differentiation and contributes to virus-induced skin disease.
Romero-Masters JC; Grace M; Lee D; Lei J; DePamphilis M; Buehler D; Hu R; Ward-Shaw E; Blaine-Sauer S; Lavoie N; White EA; Munger K; Lambert PF
PLoS Pathog; 2023 Apr; 19(4):e1011215. PubMed ID: 37036883
[TBL] [Abstract][Full Text] [Related]
19. Deficiency in
Torres AD; King RE; Uberoi A; Buehler D; Yoshida S; Ward-Shaw E; Lambert PF
J Virol; 2024 Jun; ():e0017424. PubMed ID: 38869286
[TBL] [Abstract][Full Text] [Related]
20. Immune status, strain background, and anatomic site of inoculation affect mouse papillomavirus (MmuPV1) induction of exophytic papillomas or endophytic trichoblastomas.
Sundberg JP; Stearns TM; Joh J; Proctor M; Ingle A; Silva KA; Dadras SS; Jenson AB; Ghim SJ
PLoS One; 2014; 9(12):e113582. PubMed ID: 25474466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
